These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Diiodates, triiodates and hexa-iodates in physiology and pathology of the hepatobiliary system and new views on the pathogenesis of cholecystitic processes and hepatic colic]. NUVOLI U Radiol Med; 1959 Sep; 45():817-33. PubMed ID: 14427950 [No Abstract] [Full Text] [Related]
3. [Hepatotropic contrast media]. Lazecki L Pol Przegl Radiol Med Nukl; 1972; 36(1):63-9. PubMed ID: 5012373 [No Abstract] [Full Text] [Related]
4. [On the choice of iodated media in cholecystography]. LAMBRANZI M Minerva Med; 1961 Oct; 52():3529-31. PubMed ID: 14461779 [No Abstract] [Full Text] [Related]
5. [Albumin binding of the hepatotropic contrast medium Biligrafin]. Pfab R Rontgenblatter; 1973 Jun; 26(6):282-6. PubMed ID: 4135062 [No Abstract] [Full Text] [Related]
6. [Iodinated contrast media and gastric secretion]. Puşcaş I; Buzaş G Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):447-50. PubMed ID: 44570 [No Abstract] [Full Text] [Related]
7. [Use of a hydrosoluble iodated contrast medium in radiological examination of the digestive tract in early infancy]. CATALANO D; DE BLASIO A Pediatria (Napoli); 1959; 67(3):481-90. PubMed ID: 13674796 [No Abstract] [Full Text] [Related]
8. The heterotropic excretion of intravenously injected contrast media. ARENDT J; ZGODA A Radiology; 1957 Feb; 68(2):238-41. PubMed ID: 13408501 [No Abstract] [Full Text] [Related]
10. [Sombrabil and its elimination]. SVOBODA M Cesk Rentgenol; 1955 Jun; 9(2):82. PubMed ID: 13261290 [No Abstract] [Full Text] [Related]
11. The iodinconcentration in bile during cholecystografic examination. SORENSEN B Bull Soc Int Chir; 1956 Mar; 15(2):147-50. PubMed ID: 13329693 [No Abstract] [Full Text] [Related]
12. Radiopaque contrast media. XXXVII-Iopronic acid, a new contrast medium for oral cholecystography: pharmacologic investigation. Tirone P; Rosati G Farmaco Prat; 1976 Aug; 31(8):397-412. PubMed ID: 955053 [No Abstract] [Full Text] [Related]
13. [Roentgenological proof of excretion of iodized contrast media, with quantitative iodine determination]. OTT P; OTT W Fortschr Geb Rontgenstr Nuklearmed; 1956 Apr; 84(4):447-51. PubMed ID: 13330980 [No Abstract] [Full Text] [Related]
14. [Clinical and chemical aspects of residual contrast media in the intestine during oral cholecystography with Trijobil and Falignost]. Quasdorf M; Becker C; Quasdorf G; Becker HW Radiol Diagn (Berl); 1977; 18(1):19-28. PubMed ID: 866607 [No Abstract] [Full Text] [Related]
15. [Pharmacology of oral cholecystography]. Gaón D Acta Gastroenterol Latinoam; 1980; 10(3):231-41. PubMed ID: 7013405 [No Abstract] [Full Text] [Related]
17. Studies on the absorption and excretion of a new cholecystographic agent, teridax. PERLMAN PL; KOSINSKI RE; SUTTER D J Am Pharm Assoc Am Pharm Assoc; 1955 Feb; 44(2):69-74. PubMed ID: 14353714 [No Abstract] [Full Text] [Related]
18. [Bilimiro (B 11.420) "Bracco"--a new hepatotropic contrast medium for oral cholecystography]. Lazecki L Pol Przegl Radiol Med Nukl; 1973; 37(4):509-11. PubMed ID: 4754004 [No Abstract] [Full Text] [Related]
19. [Hypersensitivity to iodated contrast media in urography. Practical importance of the basophil degranulation test]. Camussi G; Stratta P; Bosio D; Rotunno M; Dogliani M; Vercellone A Minerva Nefrol; 1979; 26(3):299-303. PubMed ID: 262268 [No Abstract] [Full Text] [Related]
20. [The effect of oral anti-diabetic agents (suphonyle ureas) on the excretion of intravenous biliary contrast media (author's transl)]. Klumair J; Pflanzer K Rofo; 1977 Jan; 126(1):66-9. PubMed ID: 137871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]